Value through Innovation27 July 2016

Clinical Study Results

  • YENTREVE ® - Diabetic Neuropathies
    Clinical Study Number 1208.34
    Study Indication Diabetic Neuropathies
    Product YENTREVE ®
    Generic Name Duloxetine
    Lab Code
    Clinical Phase IV
    Study Title

    A 12 weeks open label two parallel groups study to assess the efficacy of orally administered duloxetine 60 mg and 120 mg per day on treatment outcomes in patients with diabetic peripheral neuropathic pain with and without co-morbid major depressive disorder

    Study Document Trial synopsis1208.34 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.